Acadia Pharmaceuticals Inc.

ACADIA

[Pharmaceutical preparations and substances for the treatment of neurological, neuropsychiatric, neurodegenerative, and metabolic diseases; [ microorganisms and cultures of microorganisms for medical diagnostic use; ] chemical preparations for analyses of neurological, neuropsychiatric, neurodegenerative, and metabolic diseases and for in vivo analyses for medical diagnostic purposes];[ Chemical preparations for scientific or research use, namely, chemical preparations for analyses in laboratories and for in vitro analyses, chemical preparations for use in the discovery of novel lead compounds in the pharmaceutical industry, test kits comprised of chemical preparations, and pharmaceutical compounds for in vitro analyses of chemical compound libraries to identify compounds with activity at a given receptor, chemical preparations in the form of receptors, DNA sequences, DNA variations for use in laboratories, nucleotide sequences, including vectors, microorganisms and preparations of microorganisms for protein and gene expression ];Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; [ in vitro and in vivo research concerning the presence and functionality of organic and inorganic substances; ] consultation related thereto;

ACADIA

Pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders;

ACADIA CARES

Promoting awareness of patient support offerings for neurologic, metabolic, and genetic diseases and disorders;

ACADIA CONNECT

Providing on-line non-downloadable software for administering medical benefit and enrolling in benefits patient support program services;

ACADIA CONNECT

Educational services, namely, conducting educational programs in the fields of neurologic, metabolic, and genetic diseases and disorders and treatment and patient support options for these conditions;Printed publications in the nature of brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support;Providing a website featuring financial information regarding medical benefits and reimbursements available for medical expenses related thereto; insurance services, namely, benefits verification in the nature of insurance claims administration; providing online information and financial assistance with insurance benefits and coverage for health care providers and patients in the field of neurologic, metabolic and genetic diseases and disorders;Promoting awareness of patient support offerings for neurologic, metabolic, rare, and genetic diseases and disorders; promoting awareness of patient support offerings for pain associated with neurologic, metabolic, rare, and genetic diseases and disorders; business administration of reimbursement and medical benefit information for neurologic, metabolic, rare, and genetic conditions and their treatment; business administration of reimbursement and medical benefit information for treatment of pain associated with neurologic, metabolic, rare, and genetic conditions; Business administrative services for medical referrals;Medical consulting in the fields of neurologic, metabolic, and genetic conditions and their treatment; providing online information for health care providers and patients in the field of neurologic, metabolic and genetic diseases and disorders; medical support services, namely, providing information about the therapeutic benefits of pharmaceutical products, medical information regarding disease management, and healthcare-related information to patients and healthcare professionals in the fields of neurologic, metabolic and genetic diseases and disorders;

ELEVATE LIFE

Pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders;Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; consultation related thereto;

MORE TO PARKINSON'S

Providing information regarding the diagnosis and treatment of Parkinson's disease for patients, caregivers and health care professionals;

NUPLAZID

Pharmaceuticals preparations for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders;

NUPLAZID

The mark consists of the wording NUPLAZID in stylized indigo letters with an orange triangle forming the dot over the letter I.;Pharmaceuticals preparations for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders;The color(s) indigo and orange is/are claimed as a feature of the mark.;